CIK 0000818686 · Pharmaceutical Preparations (SIC 2834) · NYSE · incorporated in L3 · fiscal year ends 12/31
| FY2025 | FY2024 | |
|---|---|---|
| Revenue (USD) | 17.3 B | 14.9 B |
| Net income (USD) | 1.4 B | -2.4 B |
| Diluted EPS (USD/shares) | 1.21 | -2.2 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-08 | 3 | 3 | 2026-09-29 |
| 2026-09-22 | 4 | 4 | 2026-09-18 |
| 2026-09-22 | 4 | 4 | 2026-09-19 |
| 2026-09-21 | 144 | 144 | |
| 2026-09-18 | 144 | 144 | |
| 2026-09-16 | 8-K | 8-K items 1.01,2.03,9.01 | 2026-09-16 |
| 2026-09-14 | 8-K | 8-K items 8.01 | 2026-09-14 |
| 2026-09-14 | 8-A12B/A | 8-A12B/A | |
| 2026-09-14 | 25-NSE | 25-NSE | |
| 2026-09-11 | 424B5 | 424B5 | |
| 2026-09-11 | 8-K | 8-K items 7.01,8.01,9.01 | 2026-09-09 |
| 2026-09-10 | FWP | FWP | |
| 2026-09-10 | FWP | FWP | |
| 2026-09-08 | 424B5 | 424B5 | |
| 2026-09-03 | 8-K | 8-K items 8.01,9.01 | 2026-09-03 |
| 2026-09-03 | 8-K | 8-K items 3.03,9.01 | 2026-08-31 |
| 2026-08-25 | 4 | 4 | 2026-08-21 |
| 2026-08-25 | 4 | 4 | 2026-08-21 |
| 2026-08-19 | 4 | 4 | 2026-08-17 |
| 2026-08-17 | 144 | 144 | |
| 2026-08-10 | 4 | 4 | 2026-08-05 |
| 2026-08-05 | 4 | 4 | 2026-08-03 |
| 2026-08-05 | 4 | 4 | 2026-08-03 |
| 2026-08-03 | 144 | 144 | |
| 2026-08-03 | 144 | 144 |
Forms on file (last 1,000): 4 596, 8-K 92, 144 63, 3 48, 10-Q 26, 6-K 24, UPLOAD 14, CORRESP 13. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=TEVA (0.002 USD), /gw/filings/filings?ticker=TEVA&form=8-K, /gw/filings/facts?ticker=TEVA&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange